Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

556
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

793
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
793
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

4.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

376
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

647
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
647
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

359
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank.

Journal of the American Heart Association·2026
Same author

Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trial.

American journal of preventive cardiology·2026
Same author

Racism-Related Concern for Children and Central Hemodynamics in African American Women: A Longitudinal Study.

Biopsychosocial science and medicine·2026
Same author

Age at type 2 diabetes diagnosis, mortality, and health loss in South Asians.

Diabetes research and clinical practice·2026
Same author

Dyslipidemia and therapies after heart transplantation: Current evidence and future directions.

Journal of clinical lipidology·2026
Same author

The Comparative Prognostic Value of High Sensitivity Troponin Level and Stress Testing in Patients With Stable Coronary Artery Disease.

Journal of the American College of Cardiology·2026

Related Experiment Video

Updated: Mar 13, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.8K

Effects of a Health-Partner Intervention on Cardiovascular Risk.

Ibhar Al Mheid1, Heval Mohamed Kelli1, Yi-An Ko2

  • 1Emory Clinical Cardiovascular Research Institute, Emory University, Atlanta, GA.

Journal of the American Heart Association
|October 13, 2016
PubMed
Summary

A Health Partner lifestyle intervention significantly improved cardiovascular health metrics, including blood pressure and cholesterol, for two years. This program enhanced ideal cardiovascular health scores in university employees.

Keywords:
cardiovascular riskhealth educationhealth partnerlifestyleprevention

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

Related Experiment Videos

Last Updated: Mar 13, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Lifestyle modifications are primary for cardiovascular disease prevention.
  • The impact of lifestyle interventions on preserving cardiovascular health requires further examination.
  • This study investigates a Health Partner-administered lifestyle intervention's effect on ideal cardiovascular health metrics.

Purpose of the Study:

  • To evaluate the effectiveness of a Health Partner-administered lifestyle intervention.
  • To assess changes in cardiovascular health metrics following the intervention.
  • To determine the sustainability of intervention effects over two years.

Main Methods:

  • 711 university employees participated in a lifestyle intervention program.
  • Measurements of anthropometrics, labs, and physical activity were taken at baseline and at 6 months, 1 year, and 2 years.
  • A Health Partner utilized personalized results to create tailored plans for ideal health.

Main Results:

  • Significant reductions in systolic blood pressure, total cholesterol, and body mass index were observed.
  • A decrease in the percentage of smokers was noted.
  • The American Heart Association "Life's Simple 7" ideal cardiovascular health score increased significantly at all follow-up points.

Conclusions:

  • A personalized, goal-directed Health Partner intervention effectively improved cardiometabolic risk and cardiovascular health metrics.
  • These improvements were observed starting at 6 months and sustained for 2 years.
  • Further research is needed to assess long-term morbidity, mortality, and cost-effectiveness.